We are an international
independent scientific network

devoted to advancing research on optimising the prevention,
diagnosis and treatment of infectious diseases in children globally

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

Sharing values and goals

such as flexibility, commitment and transparency

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

Understanding the
immune response

so as to harness the body's response
to HIV and antiretrovirals

antimicrobial resistance

to ensure effective treatments are available
for common infections for generations to come

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

It’s time to recognise the movers and shakers in the maternal and child health field with Penta’s Brighter Future Award (BFA)!

Our 18 inspiring BFA finalists have shared their stories and on 12 December we will reveal the winners. Stay tuned for the exciting announcement!

Get to know us

Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Current Penta studies around the World

Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.





Years of activity


Ongoing studies and projects

Latest News

PediCAP project at the European & Developing Countries Clinical Trials Partnership Forum

07 Dec, 2023

The PediCAP project, dedicated to investigating antibiotic therapy for severe and very severe childhood community-acquired pneumonia, actively participated in the European & Developing Countries Clinical Trials Partnership (EDCTP) forum held…
Read More

Penta Brighter Future Awards: Meet the finalists  

29 Nov, 2023

Congratulations to the 18 finalists for Penta’s inaugural Brighter Future Award. The selected finalists have demonstrated exceptional creativity in their approaches to tackling healthcare challenges, showcasing ground-breaking solutions with the…
Read More

Advancements in paediatric HIV research: Insights from the EPIICAL general assembly meeting 

29 Nov, 2023

In the quest to enhance our understanding of paediatric HIV and improve treatment outcomes, the EPIICAL project has worked tirelessly for the past eight years to gather and generate knowledge…
Read More

World AMR Awareness Week 2023: Joining forces to combat Antimicrobial Resistance

21 Nov, 2023

As we observe World AMR Awareness Week (WAAW) 2023, the theme of “Preventing antimicrobial resistance together” serves as a stark reminder of the collective responsibility we all share in preserving the effectiveness of these…
Read More

Register for the NeoIPC webinar: “Role and potential of surveillance in preventing hospital-acquired infections among newborns”

17 Nov, 2023

Hospital-acquired infections pose a significant risk to the health and wellbeing of newborns, especially preterm babies. The NeoIPC Clinical Practice Network will be holding a webinar focusing on the role and potential of…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people